Haruna Naito

NS-187, a potent and selective dual Bcr-Abl/Lyn tyrosine kinase inhibitor, is a novel agent for imatinib-resistant leukemia

Shinya Kimura, Haruna Naito, Hidekazu Segawa et al. · Blood · 2005 · 243 citations · Full text

Antitumor Activity of Small Interfering RNA/Cationic Liposome Complex in Mouse Models of Cancer

Junichi Yano, Kazuko Hirabayashi, Shinichiro Nakagawa et al. · Clinical Cancer Research · 2004 · 238 citations

Design and synthesis of 3-substituted benzamide derivatives as Bcr-Abl kinase inhibitors

Tetsuo Asaki, Yukiteru Sugiyama, Taisuke Hamamoto et al. · Bioorganic & Medicinal Chemistry Letters · 2005 · 56 citations

Combinatorial Chemistry, Medicinal Chemistry, Derivative (Chemistry) +9

In vivo antiproliferative effect of NS-187, a dual Bcr-Abl/Lyn tyrosine kinase inhibitor, on leukemic cells harbouring Abl kinase domain mutations

Haruna Naito, Shinya Kimura · Leukemia Research · 2006 · 50 citations

Hematological Malignancy, Leukemic Cells, Mixed-phenotype Acute Leukemia +8

Structural factors contributing to the Abl/Lyn dual inhibitory activity of 3-substituted benzamide derivatives

Tatsuya Horio, Tomohiro Hamasaki, Toshihiko Inoue et al. · Bioorganic & Medicinal Chemistry Letters · 2007 · 32 citations · Full text

Combinatorial Chemistry, Molecular Pharmacology, Medicinal Chemistry +12